| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/22/2006 | EP1538927A4 Fruit and/or vegetable derived composition |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1458334B1 Yeast-based curative and care product and method for making same |
| 03/22/2006 | EP1414524B1 Treatment of hair follicle with neurokinin 1 receptor antagonists |
| 03/22/2006 | EP1411817A4 Method and apparatus for the photomodulation of living cells |
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1322162B1 Disinfectant agent |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0946155B1 Pharmaceutical composition for treating fecal incontinence and anal itch |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1750838A Medical drug containing fine particle of noble metal |
| 03/22/2006 | CN1750837A Superoxide anion decomposing agent |
| 03/22/2006 | CN1750836A Method of transdermal and transmucosal absorption of carbon dioxide and cosmetic method and therapeutic method |
| 03/22/2006 | CN1748801A Chinese medicine gauze for analgetic of scald and burn wound |
| 03/22/2006 | CN1748784A Process for producing ampeptide element |
| 03/22/2006 | CN1748772A Acne removing preparation and new preparing method |
| 03/22/2006 | CN1748768A Chinese patented medicine for catharsis and toxin expelling face nourishing and beauty |
| 03/22/2006 | CN1748767A Lupus preparation and new preparing method |
| 03/22/2006 | CN1748766A Chinese medicine composition for treating scald and its preparing method and use |
| 03/22/2006 | CN1748758A Dragon's blood gel preparation and its preparing method |
| 03/22/2006 | CN1748744A Chinese medicine for treating beri-beri and its producing method |
| 03/22/2006 | CN1748742A Itch eliminatin gel and its preparing method |
| 03/22/2006 | CN1748730A Chinese medicine zhenhuang dripping pill and its preparing method |
| 03/22/2006 | CN1748707A Use of ivermectin in treating seborrhea and using method |
| 03/22/2006 | CN1748507A Compound gaultherolin mouse expelling agent and preparing method |
| 03/22/2006 | CN1246335C Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 03/22/2006 | CN1246328C 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 03/22/2006 | CN1246323C Nitrogen-based camptothecin derivatives |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246300C Resorcinol derivatives |
| 03/22/2006 | CN1246226C UV screening compositions, product containing it and its use |
| 03/22/2006 | CN1246033C Pure Chinese herbal medicine ointment for treating skin ulcer |
| 03/22/2006 | CN1246021C Plaster for treating trauma and its preparing process and usage |
| 03/22/2006 | CN1246006C Multifunction health therapeutic external use liquid |
| 03/22/2006 | CN1246005C Chinese medicine composition for deep fungus infection |
| 03/22/2006 | CN1245979C Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245952C Depigmenting cosmetic skin-care composition and use thereof |
| 03/22/2006 | CN1245875C Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015206 Use of a polysaccharide excreted by the Vibrio diabolicus species in bone repair |
| 03/21/2006 | US7015198 Materials for soft tissue augmentation and methods of making and using same |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7014871 Iodine preparation composition |
| 03/21/2006 | US7014849 Keratinocyte culture and uses thereof |
| 03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/16/2006 | WO2006028875A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | WO2006028836A1 Wound healing |
| 03/16/2006 | WO2006028810A2 Method of wound healing using a2b adenosine receptor antagonists |
| 03/16/2006 | WO2006028724A1 Stretch mark treatment with botulinum toxic |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006028226A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | WO2006027579A2 The treatment of inflammatory disorders and pain |
| 03/16/2006 | WO2006026928A1 The vulneraria and the method for producing and using it |
| 03/16/2006 | WO2006013607A3 Composition comprising neem oil and oil extract of hypericum having healing, repellent and biocidal properties for treating external wounds |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/16/2006 | US20060058380 Novel aminobenzophenone compounds |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058329 Pyrazole inhibitors of the transforming growth factor |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058299 N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058279 Topical compositions comprising ascomycins |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057229 External skin preparations for suppressing sebum secretion |
| 03/16/2006 | US20060057133 Topical pathogenic-tissue-destroying liquid |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057093 Preparation for topical use with the function of combating hair loss |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2579540A1 The treatment of inflammatory disorders and pain |
| 03/16/2006 | CA2578933A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | CA2578702A1 Method of wound healing using a2b adenosine receptor antagonists |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634874A1 Imidazolidine derivative |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634597A1 Compositions comprising dextromethorphan and quinidine or quinine for the treatment of emotional lability |